0001532079-14-000002.txt : 20140421 0001532079-14-000002.hdr.sgml : 20140421 20140421104834 ACCESSION NUMBER: 0001532079-14-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140421 DATE AS OF CHANGE: 20140421 EFFECTIVENESS DATE: 20140421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cynapsus Therapeutics Inc. CENTRAL INDEX KEY: 0001532079 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-215923 FILM NUMBER: 14773026 BUSINESS ADDRESS: STREET 1: 828 RICHMOND STREET WEST CITY: TORONTO STATE: Z4 ZIP: M6J 1C9 BUSINESS PHONE: 416-703-2449 MAIL ADDRESS: STREET 1: 828 RICHMOND STREET WEST CITY: TORONTO STATE: Z4 ZIP: M6J 1C9 D 1 primary_doc.xml X0707 D LIVE 0001532079 Cynapsus Therapeutics Inc. 828 RICHMOND STREET WEST TORONTO A6 ONTARIO, CANADA M6J 1C9 416-703-2449 CANADA (FEDERAL LEVEL) Cannasat Therapeutics Inc. None Corporation true Anthony Giovinazzo 828 RICHMOND STREET WEST Toronto A6 ONTARIO, CANADA M6J 1C9 Executive Officer Director Andrew Williams 828 RICHMOND STREET WEST Toronto A6 ONTARIO, CANADA M6J 1C9 Executive Officer Tomer Gold 828 RICHMOND STREET WEST Toronto A6 ONTARIO, CANADA M6J 1C9 Director Ronald Hosking 828 RICHMOND STREET WEST Toronto A6 ONTARIO, CANADA M6J 1C9 Director Nan Hutchinson 828 RICHMOND STREET WEST Toronto A6 ONTARIO, CANADA M6J 1C9 Director Perry Molinoff 828 RICHMOND STREET WEST Toronto A6 ONTARIO, CANADA M6J 1C9 Director Ilan Oren 828 RICHMOND STREET WEST Toronto A6 ONTARIO, CANADA M6J 1C9 Director Alan D. C. Ryley 828 RICHMOND STREET WEST Toronto A6 ONTARIO, CANADA M6J 1C9 Director Rochelle Stenzler 828 RICHMOND STREET WEST Toronto A6 ONTARIO, CANADA M6J 1C9 Director Pharmaceuticals No Revenues 06b false 2014-04-15 true true true true true Each unit is comprised of one common share and one share purchase warrant. Each warrant is exercisable for one common share at an exercise price of Cdn$0.81 for a period of 60 months. false 0 Noble Financial Capital Markets 15768 None None 951 Yamato Road, Suite 210 Boca Raton FL FLORIDA 33431 CA CALIFORNIA FL FLORIDA IL ILLINOIS NY NEW YORK false Maddie King III 2784584 Brookline Group, LLC 153587 2501 20th Street South Suite 275 Birmingham AL ALABAMA 35223 CA CALIFORNIA FL FLORIDA IL ILLINOIS NY NEW YORK false 42916967 14546285 28370682 The additional $28,370,682 may be received upon the exercise of share purchase warrants sold inside and outside the U.S. U.S. dollar amounts are based on the Bank of Canada noon rate of exchage report on April 15, 2014, which was CN$1.0981=US$1.00. false 19 1018240 true 0 The agent also received warrants exercisable for approximately 1,720,199 shares of common stock of the issuer at a price of Cdn$0.81 per share for a period of 60 months with respect to the U.S. portion of the offering. 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Cynapsus Therapeutics Inc. /s/ Andrew Williams Andrew Williams Chief Financial Officer 2014-04-17